Arthritic Therapeutic Market by Type (Biologics and Non-biologics) and Application (Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis, and Fibromyalgia) - Global Opportunity Analysis and Industry Forecast, 2019-2026

Healthcare	LI_182571	Pages: NA	Dec 2019 \| 1589 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Arthritis is the inflammation of one or more joints, frequently accompanied by pain. There are several types of arthritis, which includes those related to wear & tear of cartilage (osteoarthritis) and that caused by an overactive immune system (rheumatoid arthritis).

The global arthritic therapeutic market growth is driven by increase in incidence of autoimmune disorders, rise in geriatric population, newer drugs in pipeline, surge in adoption rates of anti-arthritic drugs, increase in the use of anti-inflammatory therapeutics, and proactive government initiatives. However, the side effects associated with these drugs, such as serious infections, edema, ulcers; and patent expiration of certain drugs, restrain the market growth. In addition, increase in healthcare expenses and public awareness is expected to provide several opportunities for the market growth.

The global arthritic therapeutic market is segmented on the basis of type, application, and geography. On the basis of type, it is bifurcated into biologics and non-biologics. Based on application, it is categorized into rheumatoid arthritis, osteoarthritis, osteoporosis, psoriatic arthritis, ankylosing spondylitis, and fibromyalgia. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

The key companies operating in the market include AbbVie Inc., Merck & Co., Inc., Novartis AG, AstraZeneca, Abbott Laboratories, Amgen Limited & Amgen Ireland Limited, Baxter, Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Johnson & Johnson, GlaxoSmithKline plc., Celgene Corporation, and Pfizer Inc.

Key Benefits

Comprehensive analysis of the industry along with competitive rivalry is provided in the report.
In depth analysis to the current trends and future projections have been provided for the period of 2016-2023 to understand the financial appetency of the market.
The drivers, restraints, and potential opportunities in the industry along with their impact analyses have been provided in the report.
Comprehensive analysis of the various factors that drive and restrain the growth of this market is provided.
Extensive analysis of the key market players and their strategies is provided in the report.

Arthritic Therapeutic Market Key Segments:

By Type

Biologics
- Gene Therapy
- Recombinant Proteins
- Enzymes
Non-biologics
- Non-steroidal Anti-inflammatory Drugs (NSAIDs)
- Disease Modified Anti-rheumatoid Drugs (DMARDs)
- Steroids

By Application

Rheumatoid Arthritis
Osteoarthritis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia
Others

By Geography

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
LAMEA
- Brazil
- South Africa
- Saudi Arabia
- Rest of LAMEA

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Online Only ~~$3,456~~ $3,110 Data Pack/Excel ~~$3,840~~ $3,456 Single User License ~~$5,370~~ $4,833 Five User License ~~$6,450~~ $5,805 Enterprise User License ~~$8,995~~ $8,096

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com